Paul Lammers, MD

Paul Lammers, MD

Company: Triumvira Immunologics

Job title: CEO


Natural Activation of T-Cells Through the TAC Receptor Provides Ideal Characteristics for Adoptive Cell Therapy 11:30 am

Unique structure and biology of TAC T-cells Deep penetration and activation of TAC T-cells into solid tumors Update on TAC01-HER2 Phase I/II clinical trial in patients with HER2-overexpressing solid tumorsRead more

day: Conference Day Two

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.